Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. F901318
1. F-901318
2. F901318
3. 1928707-56-5
4. T34sh2h9hi
5. 2-(1,5-dimethyl-3-phenyl-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2-oxo-acetamide
6. Olorofim [inn]
7. Olorofim [who-dd]
8. Unii-t34sh2h9hi
9. Chembl4297609
10. Schembl17767345
11. Glxc-25141
12. Bcp25872
13. Bdbm50526857
14. Db15245
15. Sb19827
16. F901318; F 901318; Olorofim
17. Hy-104029
18. Cs-0025660
19. Q27896127
20. 1h-pyrrole-2-acetamide, N-(4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)phenyl)-1,5-dimethyl-.alpha.-oxo-3-phenyl-
21. 1h-pyrrole-2-acetamide, N-(4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)phenyl)-1,5-dimethyl-alpha-oxo-3-phenyl-
| Molecular Weight | 498.6 g/mol |
|---|---|
| Molecular Formula | C28H27FN6O2 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 498.21795229 g/mol |
| Monoisotopic Mass | 498.21795229 g/mol |
| Topological Polar Surface Area | 83.4 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 771 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Olorofim manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olorofim, including repackagers and relabelers. The FDA regulates Olorofim manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olorofim API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Olorofim supplier is an individual or a company that provides Olorofim active pharmaceutical ingredient (API) or Olorofim finished formulations upon request. The Olorofim suppliers may include Olorofim API manufacturers, exporters, distributors and traders.
Olorofim Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Olorofim GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Olorofim GMP manufacturer or Olorofim GMP API supplier for your needs.
A Olorofim CoA (Certificate of Analysis) is a formal document that attests to Olorofim's compliance with Olorofim specifications and serves as a tool for batch-level quality control.
Olorofim CoA mostly includes findings from lab analyses of a specific batch. For each Olorofim CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Olorofim may be tested according to a variety of international standards, such as European Pharmacopoeia (Olorofim EP), Olorofim JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Olorofim USP).
LOOKING FOR A SUPPLIER?
